Back

Beta-blockers after myocardial infarction: indication, ejection fraction, and de-escalation pathway

European Heart Journal - Cardiovascular Pharmacotherapy

13 June 2026
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE Acute Coronary Syndromes PREVENTIVE CARDIOLOGY Risk Factors and Prevention

Contributors

Na Zhang
Na Zhang

Author

Yiqun Lou
Yiqun Lou

Author

You may be interested in
thumbnail
Webinar
Are beta-blockers still indicated after myocardial infarction?
17 November 2025
thumbnail
Congress Presentation
Management of heart failure with reduced ejection fraction after ESC 2016 heart failure guidelines: the ibn rochd registry
29 June 2021
thumbnail
Congress Presentation
Mid-range ejection fraction after acute myocardial infarction
29 June 2021
thumbnail
Webinar
2022 ESC Guidelines on Cardio-Oncology: how to implement cancer treatment monitoring in daily practice
23 February 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources